1336 studies found for:    Open Studies | "Lung Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer
Condition: Lung Neoplasms
Intervention: Radiation: Radiation Concurrent Chemotherapy
22 Recruiting A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers
Conditions: Carcinoma Neuroendocrine;   Small Cell Lung Carcinoma;   Malignant Epithelial Neoplasms
Interventions: Drug: Belinostat;   Drug: Cisplatin;   Drug: Etoposide
23 Unknown  Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma
Conditions: Non-Small Cell Lung Carcinoma;   Venous Thromboembolism
Intervention: Procedure: Blood  sample withdrawal
24 Recruiting Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers
Conditions: Adenocarcinoma of the Lung;   Extensive Stage Small Cell Lung Cancer;   Limited Stage Small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Intervention: Drug: Ponatinib
25 Recruiting Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer
Conditions: Non-Small-Cell Lung Cancer Stage IIIB;   Non-Small-Cell Lung Cancer Stage IV;   Non-Small-Cell Lung Cancer Metastatic;   Carcinoma, Non-Small-Cell Lung;   Non-Small Cell Lung Cancer;   Non-Small-Cell Lung Carcinoma;   Nonsmall Cell Lung Cancer
Interventions: Biological: bavituximab;   Drug: Docetaxel;   Other: Placebo (for bavituximab)
26 Recruiting RONICICLIB / Placebo in Combination With Chemotherapy in Small Cell Lung Cancer
Condition: Small Cell Lung Carcinoma
Interventions: Drug: Roniciclib (BAY1000394);   Drug: Placebo
27 Recruiting Risk-adapted Stereotactic Body Radiotherapy for Early Non-Small Cell Lung Cancer Using the VERO Stereotactic Body Radio Therapy System
Condition: Non-Small Cell Lung Carcinoma
Intervention: Radiation: Radiotherapy (Fractionated stereotactic body radiation)
28 Not yet recruiting Icotinib for Completed Resected IB NSCLC With EGFR Mutation
Conditions: Lung Neoplasms;   Squamous Cell Lung Cancer;   Adenocarcinoma of the Lung;   Adenosquamous Cell Lung Cancer;   Large Cell Lung Cancer;   Bronchial Neoplasms;   Stage IB Non-small Cell Lung Cancer
Intervention: Drug: Icotinib
29 Unknown  First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene
Conditions: Lung Neoplasms;   Non-Small Cell Lung Cancer;   Adenocarcinoma, Bronchiolo-Alveolar
Intervention: Drug: Erlotinib
30 Unknown  Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer
Condition: Small Cell Carcinoma of Lung
Intervention: Drug: Irinotecan
31 Recruiting A Phase II Study of Doxorubicin, Cyclophosphamide and Vindesine With Valproic Acid in Patients With Refractory or Relapsing Small Cell Lung Cancer After Platinum Derivatives and Etoposide
Condition: Small Cell Lung Carcinoma
Intervention: Drug: Adriamycin, cyclophosphamide, vindesine, valproic acid
32 Recruiting Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly
Conditions: Non-Small Cell Lung Cancer;   Carcinoma;   Squamous Cell Carcinoma;   Adenocarcinoma;   Carcinoma, Large Cell;   Lung Neoplasm
Interventions: Drug: nab-paclitaxel;   Drug: Carboplatin
33 Recruiting Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma
Condition: Lung Cancer, Small Cell
Intervention: Drug: GSK2879552
34 Recruiting Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer
Condition: Small Cell Lung Carcinoma, Extensive Disease
Interventions: Drug: Cisplatin + etoposide;   Drug: Epirubicin + ifosfamide + etoposide
35 Not yet recruiting Extensive Staging in Lung Cancer
Condition: Lung Neoplasms
Intervention: Procedure: PET-MRI and EBUS-TBNA
36 Recruiting Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer
Conditions: Lung Neoplasms;   Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Metformin;   Other: Placebo Comparator
37 Recruiting Two Different Dosages of Irinotecan Combined With Cisplatin Scheme in Extensive Disease-Small Cell Lung Cancer
Condition: Small Cell Lung Carcinoma
Interventions: Drug: Irinotecan;   Drug: Cisplatin
38 Recruiting Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II
Conditions: Non-small Cell Lung Cancer;   Advanced Non-small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Hydroxychloroquine;   Drug: Bevacizumab
39 Recruiting Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously
Conditions: Lung Cancer;   Metastatic Lung Cancer
Intervention: Radiation: Stereotactic Body Radiotherapy (SBRT)
40 Recruiting Identifying Unique Scent Signature of Lung Cancer Through Body Odor
Condition: Lung Neoplasms

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years